Chao Hong Selected Research

Neoplasms (Cancer)

4/2024	Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2/STAT3/GPX4 axis.
1/2024	Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
9/2022	Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes.
6/2020	One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
1/2020	Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype.
1/2019	Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.
1/2019	The association of HLA/KIR genes with non-small cell lung cancer (adenocarcinoma) in a Han Chinese population.
2/2018	Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin.
1/2018	Genetic variation in CDH13 gene was associated with non-small cell lung cancer (NSCLC): A population-based case-control study.
1/2016	Expression, purification, and breast cancer cell inhibiting effect of recombinant human lactoferrin C-lobe.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chao Hong Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 01/2016
6	Infections 01/2023 - 10/2005
3	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2016
2	Rheumatoid Arthritis 06/2019 - 01/2013
2	Respiratory Syncytial Virus Infections 03/2009 - 06/2008
1	Colorectal Neoplasms (Colorectal Cancer) 04/2024
1	Poliomyelitis (Polio) 02/2024
1	Anthrax 05/2023
1	Convalescence 01/2023
1	Breakthrough Infections 01/2023
1	Inflammation (Inflammations) 12/2022
1	Sepsis (Septicemia) 12/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022
1	Triple Negative Breast Neoplasms 09/2022
1	COVID-19 12/2021
1	Brain Neoplasms (Brain Tumor) 10/2021
1	Glioma (Gliomas) 10/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021
1	Experimental Arthritis 06/2019
1	Brain Ischemia (Cerebral Ischemia) 03/2019
1	Ischemia 03/2019
1	Cerebral Infarction 03/2019
1	Adenocarcinoma 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Infertility (Sterility) 09/2018
1	Carcinogenesis 02/2018
1	Autoimmune Diseases (Autoimmune Disease) 02/2018
1	Pulmonary Edema 08/2014
1	Myocardial Infarction 01/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2013
1	Severe Acute Respiratory Syndrome 08/2012

Drug/Important Bio-Agent (IBA)

6	Liposomes (Liposome)IBA 01/2024 - 01/2019
4	GinsenosidesIBA 01/2024 - 01/2019
4	VaccinesIBA 01/2023 - 06/2008
4	CytokinesIBA 01/2020 - 06/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 06/2020
3	CholesterolIBA 09/2022 - 06/2020
3	Proteins (Proteins, Gene)FDA Link 02/2018 - 08/2012
3	CalreticulinIBA 02/2018 - 01/2013
2	CollagenIBA 01/2024 - 09/2022
2	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2014
2	SolutionsIBA 09/2018 - 08/2014
2	Glycoproteins (Glycoprotein)IBA 02/2018 - 01/2016
2	Phenobarbital (Luminal)FDA Link 02/2018 - 01/2013
2	AutoantigensIBA 02/2018 - 10/2013
1	baicaleinIBA 04/2024
1	flavoneIBA 04/2024
1	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 02/2024
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 02/2024
1	Metal-Organic FrameworksIBA 05/2023
1	AcidsIBA 05/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	ginsenoside Rg3IBA 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2022
1	Docetaxel (Taxotere)FDA Link 09/2022
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	ginsenoside Rh2IBA 06/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	SaponinsIBA 03/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2019
1	Neuroprotective AgentsIBA 03/2019
1	ginsenoside Rb1IBA 03/2019
1	cobaltous chloride (cobalt(II)chloride)IBA 03/2019
1	KIR ReceptorsIBA 01/2019
1	HLA-C Antigens (HLA-C)IBA 01/2019
1	Histocompatibility Antigens Class IIBA 01/2019
1	EndotoxinsIBA 09/2018
1	CalciumIBA 02/2018
1	AntigensIBA 02/2018
1	AutoantibodiesIBA 02/2018
1	H-cadherin (T-cadherin)IBA 01/2018
1	Recombinant ProteinsIBA 01/2016
1	Transferrin (beta 2 Transferrin)IBA 01/2016
1	Antimicrobial Cationic PeptidesIBA 01/2016
1	LactoferrinIBA 01/2016
1	Nitroglycerin (Dynamite)FDA LinkGeneric 08/2014
1	Verapamil (Calan)FDA LinkGeneric 08/2014
1	Peptides (Polypeptides)IBA 01/2014
1	EpitopesIBA 08/2012
1	ChemokinesIBA 07/2011
1	GTP-Binding Proteins (G-Protein)IBA 07/2011

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2019
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2019
2	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2021
2	Transplantation 12/2022 - 01/2021
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2022 - 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2014